Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

NCT00662506

Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +11 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients

NCT02575404

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +28 more
Locations: Providence Cancer Center Portland, Oregon, United States

View Trial Details

Completed

nTMS for Motor Mapping of Rolandic Lesions

NCT02879682

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +13 more
Locations: Department of Neurosurgery, Klinikum rechts der Isar, TUM Munich, Bavaria, Germany

Charité Universitätsmedizin Berlin Berlin, Germany

Vivantes Klinikum Neu-Kölln Berlin, Germany

Klinikum Bielefeld Bielefeld, Germany

View Trial Details

Completed

Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma

NCT01081223

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: Saint Luke's Hospital Kansas City, Missouri, United States

View Trial Details

Completed

HL-085 in NRAS-mutated Advanced Melanoma

NCT05217303

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Beijing Oncology Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Study of HL-085 in NRAS Mutant Advanced Melanoma

NCT03973151

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Collecting Solid Tumor Tissue to Identify New Treatments

NCT01658917

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +22 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Observational Study for Melanoma Adjuvant Treatment With Tafinlar® + Mekinist® (Dabrafenib + Trametinib)

NCT04547946

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Novartis Investigative Site Coimbra, Center, Portugal

Novartis Investigative Site Porto, North, Portugal

View Trial Details

Completed

Retrospective Assessment of AE-Related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma

NCT05874817

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Novartis East Hanover, New Jersey, United States

View Trial Details

Completed

EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas

NCT01257594

Conditions: Astrocytoma, Brain Cancer, Brain Diseases, +16 more
Locations: Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States

Columbia University Irving Medical Center New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions